Lv1
50 积分 2021-01-08 加入
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
2天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
4天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
8天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
9天前
已完结
New immune cell engagers for cancer immunotherapy
12天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
14天前
已完结
Cancer therapy with antibodies
16天前
已完结
Trends in the drug target landscape for autoimmune diseases
16天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
16天前
已关闭
Combinatorial strategies to target RAS-driven cancers
1个月前
已完结
皖公网安备34019202002308
